COVID-19 Impact on Global Leishmaniasis Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: CD2A0398A22BEN
QYResearch

Abstracts

This report focuses on the global Leishmaniasis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Leishmaniasis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Merck
• iCo Therapeutics
• AEterna Zentaris
• AEterna Zentaris AG
• Eurofins Advinus
• Pieris Pharmaceuticals
• Dafra Pharma

Market segment by Type, the product can be split into

• Meglumine Antimoniate
• Pentamidine
• Hydroxyl Amidine Stilbene
• Amphotericin B

Market segment by Application, split into

• Visceral Leishmaniasis
• Cutaneous Leishmaniasis

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Leishmaniasis Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Leishmaniasis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Leishmaniasis Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Leishmaniasis Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Leishmaniasis Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Meglumine Antimoniate
  1.4.3 Pentamidine
  1.4.4 Hydroxyl Amidine Stilbene
  1.4.5 Amphotericin B
1.5 Market by Application
  1.5.1 Global Leishmaniasis Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Visceral Leishmaniasis
  1.5.3 Cutaneous Leishmaniasis
1.6 Coronavirus Disease 2019 (Covid-19): Leishmaniasis Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Leishmaniasis Treatment Industry
    1.6.1.1 Leishmaniasis Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Leishmaniasis Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Leishmaniasis Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Leishmaniasis Treatment Market Perspective (2015-2026)
2.2 Leishmaniasis Treatment Growth Trends by Regions
  2.2.1 Leishmaniasis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Leishmaniasis Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Leishmaniasis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Leishmaniasis Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Leishmaniasis Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Leishmaniasis Treatment Players by Market Size
  3.1.1 Global Top Leishmaniasis Treatment Players by Revenue (2015-2020)
  3.1.2 Global Leishmaniasis Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Leishmaniasis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Leishmaniasis Treatment Market Concentration Ratio
  3.2.1 Global Leishmaniasis Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Leishmaniasis Treatment Revenue in 2019
3.3 Leishmaniasis Treatment Key Players Head office and Area Served
3.4 Key Players Leishmaniasis Treatment Product Solution and Service
3.5 Date of Enter into Leishmaniasis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Leishmaniasis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Leishmaniasis Treatment Forecasted Market Size by Type (2021-2026)

5 LEISHMANIASIS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Leishmaniasis Treatment Market Size by Application (2015-2020)
5.2 Global Leishmaniasis Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Leishmaniasis Treatment Market Size (2015-2020)
6.2 Leishmaniasis Treatment Key Players in North America (2019-2020)
6.3 North America Leishmaniasis Treatment Market Size by Type (2015-2020)
6.4 North America Leishmaniasis Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Leishmaniasis Treatment Market Size (2015-2020)
7.2 Leishmaniasis Treatment Key Players in Europe (2019-2020)
7.3 Europe Leishmaniasis Treatment Market Size by Type (2015-2020)
7.4 Europe Leishmaniasis Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Leishmaniasis Treatment Market Size (2015-2020)
8.2 Leishmaniasis Treatment Key Players in China (2019-2020)
8.3 China Leishmaniasis Treatment Market Size by Type (2015-2020)
8.4 China Leishmaniasis Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Leishmaniasis Treatment Market Size (2015-2020)
9.2 Leishmaniasis Treatment Key Players in Japan (2019-2020)
9.3 Japan Leishmaniasis Treatment Market Size by Type (2015-2020)
9.4 Japan Leishmaniasis Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Leishmaniasis Treatment Market Size (2015-2020)
10.2 Leishmaniasis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Leishmaniasis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Leishmaniasis Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Leishmaniasis Treatment Market Size (2015-2020)
11.2 Leishmaniasis Treatment Key Players in India (2019-2020)
11.3 India Leishmaniasis Treatment Market Size by Type (2015-2020)
11.4 India Leishmaniasis Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Leishmaniasis Treatment Market Size (2015-2020)
12.2 Leishmaniasis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Leishmaniasis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Leishmaniasis Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Merck
  13.1.1 Merck Company Details
  13.1.2 Merck Business Overview and Its Total Revenue
  13.1.3 Merck Leishmaniasis Treatment Introduction
  13.1.4 Merck Revenue in Leishmaniasis Treatment Business (2015-2020))
  13.1.5 Merck Recent Development
13.2 iCo Therapeutics
  13.2.1 iCo Therapeutics Company Details
  13.2.2 iCo Therapeutics Business Overview and Its Total Revenue
  13.2.3 iCo Therapeutics Leishmaniasis Treatment Introduction
  13.2.4 iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2015-2020)
  13.2.5 iCo Therapeutics Recent Development
13.3 AEterna Zentaris
  13.3.1 AEterna Zentaris Company Details
  13.3.2 AEterna Zentaris Business Overview and Its Total Revenue
  13.3.3 AEterna Zentaris Leishmaniasis Treatment Introduction
  13.3.4 AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2015-2020)
  13.3.5 AEterna Zentaris Recent Development
13.4 AEterna Zentaris AG
  13.4.1 AEterna Zentaris AG Company Details
  13.4.2 AEterna Zentaris AG Business Overview and Its Total Revenue
  13.4.3 AEterna Zentaris AG Leishmaniasis Treatment Introduction
  13.4.4 AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2015-2020)
  13.4.5 AEterna Zentaris AG Recent Development
13.5 Eurofins Advinus
  13.5.1 Eurofins Advinus Company Details
  13.5.2 Eurofins Advinus Business Overview and Its Total Revenue
  13.5.3 Eurofins Advinus Leishmaniasis Treatment Introduction
  13.5.4 Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2015-2020)
  13.5.5 Eurofins Advinus Recent Development
13.6 Pieris Pharmaceuticals
  13.6.1 Pieris Pharmaceuticals Company Details
  13.6.2 Pieris Pharmaceuticals Business Overview and Its Total Revenue
  13.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Introduction
  13.6.4 Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2015-2020)
  13.6.5 Pieris Pharmaceuticals Recent Development
13.7 Dafra Pharma
  13.7.1 Dafra Pharma Company Details
  13.7.2 Dafra Pharma Business Overview and Its Total Revenue
  13.7.3 Dafra Pharma Leishmaniasis Treatment Introduction
  13.7.4 Dafra Pharma Revenue in Leishmaniasis Treatment Business (2015-2020)
  13.7.5 Dafra Pharma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Leishmaniasis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Leishmaniasis Treatment Revenue
Table 3. Ranking of Global Top Leishmaniasis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Leishmaniasis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Meglumine Antimoniate
Table 6. Key Players of Pentamidine
Table 7. Key Players of Hydroxyl Amidine Stilbene
Table 8. Key Players of Amphotericin B
Table 9. COVID-19 Impact Global Market: (Four Leishmaniasis Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Leishmaniasis Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Leishmaniasis Treatment Players to Combat Covid-19 Impact
Table 14. Global Leishmaniasis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Leishmaniasis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Leishmaniasis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Leishmaniasis Treatment Market Share by Regions (2015-2020)
Table 18. Global Leishmaniasis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Leishmaniasis Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Leishmaniasis Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Leishmaniasis Treatment Players
Table 25. Global Leishmaniasis Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Leishmaniasis Treatment Market Share by Players (2015-2020)
Table 27. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leishmaniasis Treatment as of 2019)
Table 28. Global Leishmaniasis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Leishmaniasis Treatment Product Solution and Service
Table 31. Date of Enter into Leishmaniasis Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Leishmaniasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Leishmaniasis Treatment Market Size Share by Type (2015-2020)
Table 35. Global Leishmaniasis Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Leishmaniasis Treatment Market Size Share by Application (2015-2020)
Table 37. Global Leishmaniasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Leishmaniasis Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Leishmaniasis Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Leishmaniasis Treatment Market Share (2019-2020)
Table 41. North America Leishmaniasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Leishmaniasis Treatment Market Share by Type (2015-2020)
Table 43. North America Leishmaniasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Leishmaniasis Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Leishmaniasis Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Leishmaniasis Treatment Market Share (2019-2020)
Table 47. Europe Leishmaniasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Leishmaniasis Treatment Market Share by Type (2015-2020)
Table 49. Europe Leishmaniasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Leishmaniasis Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Leishmaniasis Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Leishmaniasis Treatment Market Share (2019-2020)
Table 53. China Leishmaniasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Leishmaniasis Treatment Market Share by Type (2015-2020)
Table 55. China Leishmaniasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Leishmaniasis Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Leishmaniasis Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Leishmaniasis Treatment Market Share (2019-2020)
Table 59. Japan Leishmaniasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Leishmaniasis Treatment Market Share by Type (2015-2020)
Table 61. Japan Leishmaniasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Leishmaniasis Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Leishmaniasis Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Leishmaniasis Treatment Market Share (2019-2020)
Table 65. Southeast Asia Leishmaniasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Leishmaniasis Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Leishmaniasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Leishmaniasis Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Leishmaniasis Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Leishmaniasis Treatment Market Share (2019-2020)
Table 71. India Leishmaniasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Leishmaniasis Treatment Market Share by Type (2015-2020)
Table 73. India Leishmaniasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Leishmaniasis Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Leishmaniasis Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Leishmaniasis Treatment Market Share (2019-2020)
Table 77. Central & South America Leishmaniasis Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Leishmaniasis Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Leishmaniasis Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Leishmaniasis Treatment Market Share by Application (2015-2020)
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Product
Table 84. Merck Revenue in Leishmaniasis Treatment Business (2015-2020) (Million US$)
Table 85. Merck Recent Development
Table 86. iCo Therapeutics Company Details
Table 87. iCo Therapeutics Business Overview
Table 88. iCo Therapeutics Product
Table 89. iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2015-2020) (Million US$)
Table 90. iCo Therapeutics Recent Development
Table 91. AEterna Zentaris Company Details
Table 92. AEterna Zentaris Business Overview
Table 93. AEterna Zentaris Product
Table 94. AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2015-2020) (Million US$)
Table 95. AEterna Zentaris Recent Development
Table 96. AEterna Zentaris AG Company Details
Table 97. AEterna Zentaris AG Business Overview
Table 98. AEterna Zentaris AG Product
Table 99. AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2015-2020) (Million US$)
Table 100. AEterna Zentaris AG Recent Development
Table 101. Eurofins Advinus Company Details
Table 102. Eurofins Advinus Business Overview
Table 103. Eurofins Advinus Product
Table 104. Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2015-2020) (Million US$)
Table 105. Eurofins Advinus Recent Development
Table 106. Pieris Pharmaceuticals Company Details
Table 107. Pieris Pharmaceuticals Business Overview
Table 108. Pieris Pharmaceuticals Product
Table 109. Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2015-2020) (Million US$)
Table 110. Pieris Pharmaceuticals Recent Development
Table 111. Dafra Pharma Company Details
Table 112. Dafra Pharma Business Overview
Table 113. Dafra Pharma Product
Table 114. Dafra Pharma Revenue in Leishmaniasis Treatment Business (2015-2020) (Million US$)
Table 115. Dafra Pharma Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Leishmaniasis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Meglumine Antimoniate Features
Figure 3. Pentamidine Features
Figure 4. Hydroxyl Amidine Stilbene Features
Figure 5. Amphotericin B Features
Figure 6. Global Leishmaniasis Treatment Market Share by Application: 2020 VS 2026
Figure 7. Visceral Leishmaniasis Case Studies
Figure 8. Cutaneous Leishmaniasis Case Studies
Figure 9. Leishmaniasis Treatment Report Years Considered
Figure 10. Global Leishmaniasis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Leishmaniasis Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Leishmaniasis Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Leishmaniasis Treatment Market Share by Players in 2019
Figure 15. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leishmaniasis Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Leishmaniasis Treatment Revenue in 2019
Figure 17. North America Leishmaniasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Leishmaniasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Leishmaniasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Leishmaniasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Leishmaniasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Leishmaniasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Leishmaniasis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Merck Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 26. iCo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. iCo Therapeutics Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 28. AEterna Zentaris Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. AEterna Zentaris Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 30. AEterna Zentaris AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. AEterna Zentaris AG Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 32. Eurofins Advinus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Eurofins Advinus Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 34. Pieris Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pieris Pharmaceuticals Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 36. Dafra Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Dafra Pharma Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed